Pharmafile Logo
Pharmafocus logo
Advanced Search

chemotherapy

Showing 6 posts of 21 posts found.

Onyx pharma image

Treatment shifts away from chemotherapy for multiple myeloma

December 10, 2014
Research and Development, Sales and Marketing Kyprolis, carfilzomib, chemotherapy, myeloma, onyx pharmaceuticals

Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …

News
Eisai image

FDA approves Eisai’s chemo side-effects drug

October 15, 2014
Research and Development, Sales and Marketing Eisai, FDA, Helsinn, akynzeo, chemotherapy, cinv

Eisai and Helsinn Healthcare’s Akynzeo (netupitant/palonosetron) has received FDA approval for the treatment of chemotherapy-induced nausea and vomiting (CINV). CINV …

News
Sanofi-Aventis HQ

Sanofi prostate cancer drug Jevtana approved in Europe

March 21, 2011
Sales and Marketing Jevtana, Sanofi-Aventis, TROPIC clinical trial, cabazitaxel, cancer drugs, chemotherapy, prostate cancer

Sanofi-Aventis’ new chemotherapy treatment Jevtana has followed up on its US approval last year by receiving the green light in …

News

US approval for Sanofi’s Jevtana

July 19, 2010
Sales and Marketing Jevtana, Sanofi-Aventis, chemotherapy, prostate cancer

US regulators have approved Sanofi-Aventis’ chemotherapy agent Jevtana in combination with the steroid prednisone to treat men with prostate cancer. …

News

Antisoma stages comeback with promising cancer drugs

May 20, 2010
Research and Development AML, Antisoma, chemotherapy, leukaemia

UK biotech Antisoma is looking to put previous late-stage trial failures behind it by focusing on two new cancer drugs. …

News

Oral strip ondansetron held up at FDA

February 11, 2010
Manufacturing and Production, Research and Development Strativa, chemotherapy, film strips, nausea

A novel formulation of ondansetron has seen its marketing application delayed at the US Food and Drug Administration (FDA) because …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026